Steven is the Founder and Managing Director of Vaxa Inc. His background spans executive strategy, partnerships, channel development, venturing, and practice building — across a range of enterprise clients and industries, from Fortune 500 technology companies to early-stage medical device startups. He has sat on both sides of the table — as an advisor and a corporate executive — and brings that dual perspective to every engagement. His work spans decades and continents, with clients ranging from global technology firms to growth-stage ventures entering new markets for the first time.

​

He holds an MBA in Strategy & Economics, BS Engineering, and Specialization in Capital Formation.

Kevin has 25+ years of strategy and venturing experience. He led Vaxa client engagements for growth-stage startups and Fortune 500 companies across technology, healthcare, consumer, industrials, and telecom, building growth strategies that held up under real market conditions.

​

Some of his seminal work includes assisting a healthtec company to transition into clinical trials, uncovering new forms of video gaming genres, and working with startups to raise early stage funding.

​

He holds an MBA and advanced degrees in Finance and Management.

Marcello Bondurant is a Director and lead consultant on Vaxa engagements, specializaing in emerging markets.

 

He brings significant depth of experience to growth strategy assignments, with particular strength in nascent opportunity analysis. His qualitative and quantitative analytical capabilities allow him to direct research for maximum insight — making sense of complex, ambiguous emerging markets and surfacing new growth opportunities by connecting the dots in ways the create breakthrough growth.

​

Holds an MBA and MS in Finance with expertise in Banking operations.

​

Michael is a visionary thought leader in pharmaceutical drug discovery and development. He was previously Director of Computational Biology & Bioinformatics at the University of Pennsylvania School of Medicine, and held similar positions at Roche Pharmaceuticals and Wyeth. He serves on twelve international scientific boards and is an Invited Professor at the Shanghai Center for Bioinformatics Technology.

​

He holds a PhD in Theoretical Chemistry and Protein Crystallography

​

Michael is a thought leader in pharmaceutical drug discovery and development. He was previously Director of Computational Biology & Bioinformatics at the University of Pennsylvania School of Medicine, and held similar positions at Roche Pharmaceuticals and Wyeth. He serves on twelve international scientific boards and is an Invited Professor at the Shanghai Center for Bioinformatics Technology.

​

He holds an MBA, MS and BS in Healthcare & Life Sciences

​

Ryan leadsprimary and secondary research across Vaxa engagements. He is particularly effective at rapidly building subject matter expertise in complex emerging market topics — becoming the go-to resource for the team on areas that require deep and fast immersion. His assignments span e-commerce, CRM, IP analysis, segmentation modeling, pricing, and channel strategy across Fortune 500 corporations and SMB clients.

​

He holds an MBA, BA in Economics

​

Fred has over 20 years experience working across sectors ranging from mortgage securities, consumer credit, behaviorial analytics, to banking. He channels experience into analyzing vast amount of complex data and come out on the other side with insights that are far reaching for clients.

​

He holds an MBA with a specialization supply chain management.

​

Gayle is a growth and innovation strategy consultant who has worked directly with senior decision-makers at Fortune 1000 companies, across technology, healthcare, pharmaceuticals, cloud SaaS, consumer packaged goods, entertainment, and utilities. She's known for running fast, high-energy working sessions — from executive strategy meetings to market immersions — that end with a clear plan, not another deck to interpret.

​

She lives in Napa, California, with her husband.

​

Troy has two decades of research and quantitative modeling experience to client engagements. His background is built on rigorous data analysis, statistical modeling, and evidence standards most consultants only encounter in theory. At Vaxa, Troy applies that research and modeling discipline to client work — bringing a level of analytical rigor to data and evidence that comes from having actually practiced it, not just studied it.

​

He holds a DPhil in Biomedical Engineering